HMGCR and atherosclerosis: By inhibiting the enzyme HMG-CoA reductase, statins reduce cholesterol synthesis in the liver, leading to a decrease in circulating LDL-C levels, which is directly linked to reduced atherosclerosis and lowered CV event risk.